Phase 2 cohort
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Phase 1 | interacts_with | Phase 2 | — | 1 |
| Phase 2 | associated_with | Huntington's disease | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects. (2023)
- Genetic variants associated with longitudinal changes in brain structure across the lifespan. (2022)
- Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder. (2021)
- Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. (2014)
- Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. (2011)
- Toward a neurobehavioral profile of fetal alcohol spectrum disorders. (2010)
- From child maltreatment to adolescent cannabis abuse and dependence: a developmental cascade model. (2010)
- Collaborative initiative on fetal alcohol spectrum disorders: methodology of clinical projects. (2010)
- Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. (2009)
- The law of attrition. (2005)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| phase 2 | cohort | 7 | 15 |
| phase ii | cohort | 3 | 10 |
| hold-out set | cohort | — | — |
| phase 2 cohort | cohort | — | — |